Barth syndrome
Sarah Ln Clarke,Ann Bowron,Iris L. Gonzalez,Sarah J. Groves,Ruth Newbury-Ecob,Nicol Clayton,Robin P. Martin,Beverly Tsai-Goodman,Vanessa Garratt,Michael Ashworth,Valerie M. Bowen,Katherine R. McCurdy,Michaela K. Damin,Carolyn T. Spencer,Matthew J Toth,Richard I. Kelley,Colin G. Steward +16 more
Reads0
Chats0
TLDR
The Barth syndrome (BTHS) is a rare X-linked genetic disease characterized by cardiomyopathy (CM), skeletal myopathy, growth delay, neutropenia and increased urinary excretion of 3-methylglutaconic acid (3-MGCA) as mentioned in this paper.Abstract:
First described in 1983, Barth syndrome (BTHS) is widely regarded as a rare X-linked genetic disease characterised by cardiomyopathy (CM), skeletal myopathy, growth delay, neutropenia and increased urinary excretion of 3-methylglutaconic acid (3-MGCA). Fewer than 200 living males are known worldwide, but evidence is accumulating that the disorder is substantially under-diagnosed. Clinical features include variable combinations of the following wide spectrum: dilated cardiomyopathy (DCM), hypertrophic cardiomyopathy (HCM), endocardial fibroelastosis (EFE), left ventricular non-compaction (LVNC), ventricular arrhythmia, sudden cardiac death, prolonged QTc interval, delayed motor milestones, proximal myopathy, lethargy and fatigue, neutropenia (absent to severe; persistent, intermittent or perfectly cyclical), compensatory monocytosis, recurrent bacterial infection, hypoglycaemia, lactic acidosis, growth and pubertal delay, feeding problems, failure to thrive, episodic diarrhoea, characteristic facies, and X-linked family history. Historically regarded as a cardiac disease, BTHS is now considered a multi-system disorder which may be first seen by many different specialists or generalists. Phenotypic breadth and variability present a major challenge to the diagnostician: some children with BTHS have never been neutropenic, whereas others lack increased 3-MGCA and a minority has occult or absent CM. Furthermore, BTHS was first described in 2010 as an unrecognised cause of fetal death. Disabling mutations or deletions of the tafazzin (TAZ) gene, located at Xq28, cause the disorder by reducing remodeling of cardiolipin, a principal phospholipid of the inner mitochondrial membrane. A definitive biochemical test, based on detecting abnormal ratios of different cardiolipin species, was first described in 2008. Key areas of differential diagnosis include metabolic and viral cardiomyopathies, mitochondrial diseases, and many causes of neutropenia and recurrent male miscarriage and stillbirth. Cardiolipin testing and TAZ sequencing now provide relatively rapid diagnostic testing, both prospectively and retrospectively, from a range of fresh or stored tissues, blood or neonatal bloodspots. TAZ sequencing also allows female carrier detection and antenatal screening. Management of BTHS includes medical therapy of CM, cardiac transplantation (in 14% of patients), antibiotic prophylaxis and granulocyte colony-stimulating factor (G-CSF) therapy. Multidisciplinary teams/clinics are essential for minimising hospital attendances and allowing many more individuals with BTHS to live into adulthood.read more
Citations
More filters
Journal ArticleDOI
Re-Expression of Tafazzin Isoforms in TAZ-Deficient C6 Glioma Cells Restores Cardiolipin Composition but Not Proliferation Rate and Alterations in Gene Expression
Gayatri Jagirdar,Matthias Elsner,Christian Scharf,Stefan Simm,Katrin Borucki,Daniela Peter,Michael Lalk,Karen Methling,Michael Linnebacher,Mathias Krohn,Carmen Wolke,Uwe Lendeckel +11 more
TL;DR: This study investigated if specific isoforms like Δ5 can restore the wild type phenotype with respect to CL composition, cellular proliferation and gene expression profile, and determined the molecular mechanism by which tafazzin can modulate gene expression by applying promoter analysis and IPA to genes regulated by TAZ-deficiency.
Journal ArticleDOI
Analysis of tafazzin and deoxyribonuclease 1 like 1 transcripts and X chromosome sequencing in the evaluation of the effect of mosaicism in the TAZ gene on phenotypes in a family affected by Barth syndrome.
TL;DR: In this paper , a new mutation (c.83 T>A, p.Va28Glu) was found in the TAZ gene in two affected patients with congenital cardiomyopathy.
Book ChapterDOI
Cardiac Complications of Neuromuscular Disorders
TL;DR: In this article , a multidisciplinary approach including a cardiologist is essential to optimize care for the patient with a neuromuscular disorder, including Duchenne muscular dystrophy.
Journal ArticleDOI
Tafazzin deficiency attenuates anti-cluster of differentiation 40 and interleukin-4 activation of mouse B lymphocytes
Hana M. Zegallai,Ejlal Abu-El-Rub,Edgard M. Mejia,Genevieve C. Sparagna,Laura K. Cole,Aaron J. Marshall,Grant M. Hatch +6 more
TL;DR: It is shown that Taz is required to support T-cell-dependent signaling activation of mouse B cells and this results indicate that BTHS patients are susceptible to serious infections.
Journal ArticleDOI
Narrative review of pediatric heart failure in the age of precision medicine
TL;DR: In this paper , the authors conducted a comprehensive database search (January 2000-August 2022) of PubMed, utilizing terms ‘pediatric’, ‘cardiomyopathy and heart failure,’ as well as tailored therapies to specific molecular causes.
References
More filters
Journal ArticleDOI
The biosynthesis and functional role of cardiolipin.
Journal ArticleDOI
A novel X-linked gene, G4.5. is responsible for Barth syndrome
Silvia Bione,Patrizia D'Adamo,Elena Maestrini,Agi K. Gedeon,Pieter A. Bolhuis,Daniela Toniolo +5 more
TL;DR: The results suggest that G4.5 is the genetic locus responsible for the Barth syndrome, and introduces stop codons in the open reading frame interrupting translation of most of the putative proteins.
Journal ArticleDOI
An X-linked mitochondrial disease affecting cardiac muscle, skeletal muscle and neutrophil leucocytes
Peter G. Barth,Hans R. Scholte,J.A. Berden,J.M. Van Der Klei-Van Moorsel,I.E.M. Luyt-Houwen,E.Th. Van'T Veer-Korthof,J.J. Van Der Harten,M.A. Sobotka-plojhar +7 more
TL;DR: Biochemical studies and haematological abnormalities (neutropenia) are reported for the first time in an X-linked recessive disease reported in a large pedigree of boys.
Journal ArticleDOI
The epidemiology of childhood cardiomyopathy in Australia.
Alan Nugent,Piers E.F. Daubeney,Patty Chondros,John B. Carlin,Michael Cheung,Lynette C. Wilkinson,Andrew M. Davis,Stephen G. Kahler,Chung Wo Chow,James L. Wilkinson,Robert G. Weintraub +10 more
TL;DR: The timing and severity of presentation in children with cardiomyopathy are related to the type of cardiomeopathy, as well as to genetic and ethnic factors.
Journal ArticleDOI
Clinical Characterization of Left Ventricular Noncompaction in Children A Relatively Common Form of Cardiomyopathy
Ricardo H. Pignatelli,Colin J. McMahon,William J. Dreyer,Susan W. Denfield,Jack F. Price,John W. Belmont,William J. Craigen,Jen Wu,Howaida G. El Said,Louis I. Bezold,Sarah K. Clunie,Susan D. Fernbach,Neil E. Bowles,Jeffrey A. Towbin +13 more
TL;DR: A significant number of patients with LVNC have transient recovery of function followed by later deterioration, which may account for many patients presenting as adults, some manifesting an “undulating” phenotype.